It is a healthcare private limited company based in Miraj, Maharashtra, India, established in 2014.
2014 | Miraj, Maharashtra, India | ActiveShiv Cancer Institute Private Limited, a active private limited company, was established on 10 January 2014 in Miraj, Maharashtra, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85100PN2014PTC150127. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a compliant status. Its leadership includes Leela Sharad Desai (Director), Sharad Shankar Desai (Director). It holds ₹1.13 Cr open charges and ₹8.76 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 795/A,1/3A/1/4, Mahatma Gandhi Cancer Hospital, Budhagaonkar Mala, Shaskiya Dudh Dairy R, D,Zari Bag, Miraj, Maharashtra, 416410.
U85100PN2014PTC150127
150127
10 January 2014
₹3.00 Cr
₹2.00 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Shiv Cancer Institute Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Leela Sharad Desai | Director | 10 Jan 2014 | Current |
| Sharad Shankar Desai | Director | 10 Jan 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shiv Cancer Institute Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.65% increase. The company also saw a substantial improvement in profitability, with a 373.44% increase in profit. The company's net worth Soared by an impressive increase of 21.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Shiv Cancer Institute had a public holding of 43.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹11,250,000.00
₹87,560,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2015 | Shri Veershaiv Co-Op Bank Ltd | ₹1.13 Cr | Open |
| 18 Feb 2017 | Tjsb Sahakari Bank Limited | ₹6.45 M | Satisfied |
| 07 Dec 2015 | Tjsb Sahakari Bank Limited | ₹1.22 M | Satisfied |
| 15 Oct 2015 | Tjsb Sahakari Bank Limited | ₹1.45 M | Satisfied |
| 29 Sep 2015 | Tjsb Sahakari Bank Limited | ₹1.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Shiv Cancer Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shiv Cancer Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiv Cancer Institute's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shiv Cancer Institute Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Shiv Cancer Institute Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Progress on A charge registered on 18 Feb 2017 via Charge ID 100082830 with Tjsb Sahakari Bank Limited was fully satisfied on 24 Mar 2021. was documented.
The activity A charge registered on 07 Dec 2015 via Charge ID 10610580 with Tjsb Sahakari Bank Limited was fully satisfied on 24 Mar 2021. was completed.
Progress on A charge registered on 15 Oct 2015 via Charge ID 10600038 with Tjsb Sahakari Bank Limited was fully satisfied on 24 Mar 2021. was documented.
The activity A charge registered on 29 Sep 2015 via Charge ID 10596492 with Tjsb Sahakari Bank Limited was fully satisfied on 24 Mar 2021. was completed.
The CIN of Shiv Cancer Institute Private Limited is U85100PN2014PTC150127.
Shiv Cancer Institute Private Limited is headquartered at 795/A,1/3A/1/4, Mahatma Gandhi Cancer Hospital, Budhagaonkar Mala, Shaskiya Dudh Dairy R, D,Zari Bag, Miraj, Maharashtra, 416410.
Shiv Cancer Institute Private Limited was incorporated on 10 January 2014.
The current directors of Shiv Cancer Institute Private Limited are
The primary industry of Shiv Cancer Institute Private Limited is Hospital And Medical Care.
Shiv Cancer Institute Private Limited is unlisted.
The authorized capital of Shiv Cancer Institute Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Shiv Cancer Institute Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX